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By reacting trimethylammoniobromobimane bromide (TMB bromide) with rabbit muscle actin, a fluorescent reporter group was linked to cysteine 
at position 374. Fluorescence of TMB-actin decreased significantly on addition of thymosinp4 (T/94), a peptide of 43 amino acid residues reported 
to bind to monomeric actin and to prevent filament formation, Based on this effect, we determined the Kn value of the thymosin @l complex as 
0.8 PM, a value that is in agreement with previous determinations. In addition to the main compound thymosin/?4, bovine tissue contains a related 
peptide, thymosin p (Tp9), which has 41 amino acid residues and ca. 75% sequence homology. In the present study we show for the first time 
that T/$?, similar to Tp4, forms a 1:l complex with monomeric actin, and hereby inhibits actin polymerization. With a K, value of 1.1 FM the 
affinity of TjT9 is in the same range as that of Tp4, suggesting that T@9, like T/?4, contributes to maintaining the pool of monomeric. actin in bovine 
non-muscle cells. Further proof of the interaction of T/I9 with actin was provided by native PAGE, where the complex showed the reported higher 
mobility, as well as by crosslink~g experiments. Using different crosslinking reagents, like water-soluble ~~iimide (EDC), ~-maleimido~~oyl- 
~-hydroxys~nimi~te (MBS), and disu~inimidylsu~rate (DSS), we were able to produce conjugates of 47 kDa. In one of these (from MBS) 
both actin and Tfi9 could be identified by imm~oblot~ng. When, in the MBS crosslinking experiments, native actin was replaced with (374-NEM)- 
actin, the 47 kDa band was not seen, indicating that Cys-374 takes part in the thiol-specific rosslinking reaction. This suggests that part of the 
binding site of T/39 must be located close to the carboxy-terminus. 
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1. INTRODUCTION 
In non-muscle cells the ~cro~~ent system is dy- 
namic in nature. Rapid appearance of filaments in re- 
sponse to various stimuli to the cell is made possible by 
the existence of a pool of actin monomers which may 
account for up to 50-60% of total actin in the cell. A 
high concentration of monomeric actin is not expected 
to exist in the cytoplasm, since the ionic conditions 
favor polymerization; it is therefore believed that in 
non-muscle cells the pool of unpolymerized actin is 
maintained through complexation of monomers with 
small actin-sequestering proteins, such as protiin or 
actobindin [I]. 
Very recently Safer et al. [2,3] reported that thymosin 
84 (Tp4) has actin-sequestering properties. Tp4 is the 
main component of a family of peptides (4-5 kDa) 
which originally were isolated from calf thymus [4] and 
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became known for their T-cell-modulating activities. 
Besides TB4, a second peptide, ‘I&9, was found associ- 
ated with 1184 in bovine tissue and has ca. 75% sequence 
homology [5,6]. Other species, such as man and rat, 
contain T@lO instead of Tj?9 [7]. While in plasma the 
concentration of Tp4 is low (ca. 2.5 nM [8]), a much 
higher concentration was found inside cells (ca. 600 ,uM 
in the cytoplasm of platelets [7,9]). This led to the sug- 
gestion that the main physiological role of j&thymosins 
may be other than in modulating immune activities. 
One such possibility is that /?-thymosins play a role in 
the regulation of the microfilament system. 
Here we report that the action of TB9 resembles that 
known for T/34 [2,3] and recently reported for Tj?lO [lo]. 
For studying the complexes of ~-th~osins with mon- 
omeric actin we established an assay system based on 
a change in fluorescence that is induced in a TMB deriv- 
ative of actin on the addition of @hymosins. 
2. MATERIALS AND METHODS 
Actin was prepared as described by Spudich and Watt [ll] and 
further puriBed by a gel-filtration step on a Fractogel TSK HW 55 
(MERCK; Darmstadt) column (3 x 120 cm) in buffer G (2 mM Tris, 
0.2 mM ATP, 0.1 mM CaCl,, 0.02% NaN,, pH 7.8). 
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Tp9 was isolated together with Tp4 from bovine lung, following a 
procedure described for the isolation of these peptides from bovine 
tissue [15]. Separation of T/I9 from Tp4 was achieved using prepara- 
tive isoelectric focussing based on different pI values of the two pep- 
tides, which are 4.6 and 5.1, respectively. After semipreparative HPLC 
on RP18, T/I9 was obtained pure as assessed by analytical HPLC. 
2.1. (Cys-374) TMB-actin 
To a solution of G-a&in (ca. 3 mg protein per ml) in buffer G an 
8-fold excess of TMB bromide (Thiolyte MQ; Calbiochem, Bad 
Soden. Germany) in methanol was added and reacted at 4°C for 2 h. 
The mixture was applied to a Sephadex G-25 column (I x 25 cm) 
equilibrated with buffer G in order to remove excess reagent. 
2.2. Fluorescence measurements 
The fluorescence of TMB-actin in buffer G (2 ,uM in fluorescence 
cuvettes) was measured in a Spex fluorolog (Spex Industries Inc., New 
York) between 385 and 600 nm (excitation 370 nm). Thenp-thymosins 
(O-12 ,uM) were added, and after incubation for 15 min at room 
temperature the changed fluorescence spectra were recorded and the 
Kn values were calculated from the integrated spectra according to 
Pesce et al. 1121. 
2.3. Viscasimetric me~~ements 
Polymerization was monitory in a Cannon Capillary viscosimeter, 
using a 9.5 ,vM ~on~ntration of G-a&t in buffer G, to which MgCl, 
was added to a final con~n~tion of 1 mM. For studying the polym- 
erization in the presence of T@9, the peptide was added to the actin 
solution to final concentrations of 2.4, 4.8, 7.1 and 9.5 PM, and 
allowed to stand for 15 min at room temperature (RT) before polym- 
erization was started. 
2.4. Native PAGE 
This was performed as described by Safer et al. [2,13] using a buffer 
containing 25 mM Tris, 0.194 M glycine, 0.3 mM ATP, 0.1 mM CaCl,. 
Actin and T/I9 in equimolar amounts were incubated for 30 min at 4°C 
before the start. In experiments without Ca’+, 1 mM EGTA was 
added. 
2.5. Crosslink~g exper~ents with MBS 
To a mixture of equimolar amounts of G-a&n and T@ in buffer 
G, preincubated for 15 min at RT, a 50-fold excess of m-maleimido- 
benzoyi-N-hydroxysuccinimidate dissolved in dimethylfo~~ide/ 
water (50/50 ~01%) was added. After 3 h the reaction was stopped with 
a 200-fold excess of 2-mercaptoethanol. The mixture was analysed by 
SDS-PAGE (12.5%). In a control experiment (Cys-374)Neth- 
ylmaleimide actin was used instead of native actin. 
2.6. Crosslinking experiments with EDCIN-hydroxysuccinimide 
G-actin in 2 mM MOPS pH 6.0 containing 0.2 mM ATP and 0.1 
mM CaCl, was reacted with 2 mM EDUS mM N-hydroxysuccinimide 
for 30 min at 4°C. After the pH had been adjusted to 7.8 by adding 
2 mM MOPS buffer pH 9.5, an equimolar amount of T@9 was added. 
Reaction was stopped after 30 min, and the mixture analyzed as above. 
2.7. Crosslinking experiments with DSS 
A 1:l mixture of G-a&in in buffer G and T/I9 was incubated at 4°C 
for 15 min with a 50-fold molar excess of disuccinimidylsuberate; he 
reaction was stopped by the addition of Tris and the mixture analysed 
by SDS-PAGE. 
2,8. SDS-PAGE and immunoblotting 
SDS-PAGE was conducted on 12.5% gels. Immunoblotting was 
done on Immobilon membranes (Millipore); non-specific binding was 
blocked by 3% skimmed milk in PBS. Mouse anti-actin antibodies 
(Amersham) and rabbit anti-T/?4 antiserum were used as primary 
antibodies. The bound antibodies were detected by peroxidase-conju- 
gated second antibodies (anti-moue, and anti-rabbit IgG, respec- 
tively; Dianova, Hamburg). 
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3. RESULTS AND DISCUSSION 
In G-actin in the presence of ATP, only the thiol 
group in position 374 is exposed [14]. Alkylation of this 
SH group with Thiolyte MQ yielded a conjugate con- 
taining 0.7 moles of label per mol of actin. As Fig. 1 
shows, the fluorescence of this label was decreased on 
the addition of Tfl4 in a dose-dependent way. Evalua- 
tion of the fluorescence data yielded an apparent Kn 
value of 0.8 + 0.10 PM. This value is in the same range 
as that reported by Weber et al. [9] on the basis of 
kinetic measurements with gelsolin-capped filaments 
(Kn = 2 PM). A similar set of fluorescence data as 
shown in Fig. 1 was obtained with T/I9 (not shown). The 
apparent KD value of Tp9 was 1.1 f 0.11 ,uM, indicating 
that this peptide interacts with monomeric actin in a 
way similar to Tj54. 
The biological activity of T/39 was assessed by sub- 
jecting equimolar amounts of the peptide and G-a&in 
to polymerization conditions. On the addition of 1 mM 
MgCI, no increase in viscosity was observed in a capil- 
lary viscosimeter. This indicates that T@9, like T/I4, is 
able to prevent actin polymerization. As shown in Fig. 
2 the effect is dose-dependent and suggests the existence 
of a 1:l complex, similar to Tp4. The fact that relative 
viscosity falls to zero already at a ratio of 0.751 is 
explained by the presence of uncomplexed monomers 
(critical concentration) and oligomers that do not con- 
tribute to viscosity. 
Evidence for the physical interaction of Tp9 and actin 
was obtained from native gel electrophoresis, as de- 
scribed recently for T/I4 by Safer and co-workers [2,13]. 
Fig. 3 shows that the complex of T/$9 and actin can 
easily be identified on the basis of its mobility, which 
exceeds that of pure actin. Gels run in the presence or 
in the absence of 0.1 mM CaCI, showed no difference, 
suggesting that formation of the complex between T/I9 
and actin is independent of Ca2+ ions. This is in agree- 
ment with data published by Weber et al. [9] who found 
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Fig. 1. Change in the fluorescence spectrum of TMB-actin (trace 1) 
with increasing amounts of T/34 added (traces 2-6). 
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Fig. 2. Plot of the relative viscosity values q (plateau values) against 
the ratio of TB9 and actin. 
that the Kn of Tp4 was identical in the presence of 0.2 
mM Ca2’ or 5 mM EGTA. 
Additional evidence for the existence of a complex of 
T@9 and actin was obtained from crosslinking experi- 
ments. We examined three different crosslinking rea- 
gents: the zero-length crosslinker, EDC, leading to the 
formation of an isopeptide bond; the amino-specific S- 
atom crosslinker, DSS; and the heterobifunctional 7- 
atom crosslinker, MBS, which allows crosslinking be- 
tween a thiol and an amino group. All three crosslinking 
experiments were positive, as shown by the appearance 
of a 47 kDa band in SDS-PAGE (Fig. 4). The conjugate 
obtained by crosslinking with MBS was further charac- 
terized by Western blotting. Using antiserum against 
T/I4 exhibiting 35% cross-reactivity against T/?9 [15] in 
an ELISA, we were able to detect T/39 in the covalently 
AK AKj39 AK 
Fig. 3. Native PAGE of actin and the actin-Tj?9 complex. Lanes 1, 3, 
actin; lane 2, complex of actin and Tj9. Stained with Coomassie blue. 
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Fig. 4. 12.5% SDS-PAGE on the crosslinking experiments of actin 
with TjI9. Lane 1, actin, Tfl (1:l) with EDC/NHS, lane 2, actin, TB9 
(1:l) with DSS; lane 3, actin, T/Y9 (1:l) with MBS; lane 4, actin. 
linked state (data not shown). Based on this possibility, 
and using the same antiserum in combination with anti- 
bodies against actin, we could show that the 47 kDa 
band seen in SDS-PAGE contains both actin and T/?9 
(Fig. 5). 
Crosslinking was likewise obtained with TB9 and 
ADP-G-actin. This reaction occurred even when an 
ADP-G-actin was used in which the reported confor- 
mational transition had uncovered Cys- 10 [ 161 (data not 
shown). Crosslinking experiments clearly give no infor- 
mation on the stability of the complexes formed from 
T/I9 and the various actin species, like an ATP-actin 
and the two ADP-actins; this question is interesting in 
the light of the suggestion that a retarded exchange of 
the nucleotide in the actin-thymosin complex (in combi- 
nation with accelerated exchange in the profilin-actin 
complex) may be of importance for the regulation of the 
actin equilibrium in non-muscle cells [17]. 
From the reaction product with one of the crosslink- 
ers, MBS, preliminary information could be obtained 
on the binding site of /?-thymosins on the actin surface. 
Since Tp9 contains no cysteine residues, and actin under 
the given conditions exposes only one thiol group, the 





Fig. 5. SDS-PAGE and immunoblot of actin (lanes 1,3,5) and actin 
crosslinked with T/?9 (MBS) (lanes 2,4,6). Lanes 1,2, SDS-PAGE 
(stained with Coomassie blue); lanes 3,4, immunoblot using mouse 
anti-actin antibody: lanes $6, immunoblot using rabbit anti-T/34 an- 
tiserum. 
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Fig. 6.12.5% SDS-PAGE of the MBS crosslinking experiment. Lanes: 
(1) actin; (2) ‘74NEM-actin; (3) actin, T/J9 (1: 1) with MBS added; (4) 
374NEM-actin, Tfl (1:l) with MBS added. 
involves the thiol group of Cys-374. This was shown by 
replacing native actin by (374-NEM)-actin in the 
crosslinking reaction. As expected, the 47 kDa band of 
the complex was not seen in the SDS-PAGE (Fig. 6), 
suggesting that crosslinking failed because the thiol 
group 374 was not available. In a control experiment it 
was shown that T/I9 inhibits the polymerization of (Cys- 
374) NEM-actin as efficiently as that of the native actin, 
excluding the possibility that the negative result of the 
crosslinking experiment was due to a loss of thymosin- 
binding capacity in the (374-NEM)-actin. From of 
these results we thus conclude that at least a part of the 
/I-thymosin molecule must be located in close vicinity to 
the carboxy-terminus of actin. 
More information on the binding site of T/?9 on the 
actin molecule was obtained from studying the DNase 
I inhibition capacity of actin in the presence of the 
peptide. Using the DNase I assay of Blikstadt et al. [18] 
we were able to show that G-actin in the presence of T/J9 
is unable to inhibit the enzymatic activity. This suggests 
that actin cannot bind T/I9 and DNase I at the same 
time. This is difficult to understand because DNase I 
has been reported to bind to subdomains 2 and 4 of the 
actin monomer [19], distant from the carboxy-terminus. 
Possible explanations for this inconsistency are that ei- 
ther the binding sites of DNase I and T/I9 overlap, 
despite the large distance, which would be in line with 
the stretched conformation of the peptide suggested on 
the basis of NMR studies [20]. Alternatively binding of 
T/I9 may induce a conformational change in the actin 
monomer that excludes imultaneous binding of DNase 
I. 
In conclusion, it has been shown that not only the 
major component of the /I-thymosins, Tp4, but also a 
minor component such as TB9, which is associated with 
TB4, has an actin-sequestering activity. This result is in 
line with the recent finding that T/I10 also has the same 
biological activity [10,21]. By using a novel fluorescence 
assay system we have shown that the complexes of actin 
with T/I9 and T/I4 are of comparable stability. The ques- 
tion as to whether or not the cellular concentration of 
/I-thymosins is high enough to match the concentration 
of actin monomers now has to consider the contribution 
of other components of the /I-thymosin family as well. 
The fact that various &thymosins possessing different 
lengths and up to 30% variation in primary structure 
can have similar or identical biological activities 
strengthens the idea that sequestration of actin is the 
major physiological role of these peptides. 
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